These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19229817)

  • 21. [Cardiorenal syndrome].
    Portolés Pérez J; Cuevas Bou X
    Nefrologia; 2008; 28 Suppl 3():29-32. PubMed ID: 19018735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal function impairment in peripheral arterial disease: an important parameter that should not be neglected.
    Paraskevas KI; Giannoukas AD; Mikhailidis DP
    Ann Vasc Surg; 2009; 23(5):690-9. PubMed ID: 19747617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal function predicts cardiovascular outcomes in southern Italian postmenopausal women.
    Perticone F; Sciacqua A; Maio R; Perticone M; Laino I; Bruni R; Cello SD; Leone GG; Greco L; Andreozzi F; Sesti G
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):481-6. PubMed ID: 19531955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of renal dysfunction as a cardiovascular risk factor.
    Adamczak M; Ritz E
    Rocz Akad Med Bialymst; 2005; 50():50-3. PubMed ID: 16358939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age- and gender-specific values of estimated glomerular filtration rate among 6232 patients undergoing cardiac surgery.
    Diez C; Mohr P; Koch D; Silber RE; Schmid C; Hofmann HS
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):593-7. PubMed ID: 19584070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components.
    Alpert MA; Govindarajan G; Del Rosario ML; Reisin E
    J Cardiometab Syndr; 2009; 4(1):57-62. PubMed ID: 19245518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The scope of coronary heart disease in patients with chronic kidney disease.
    Hage FG; Venkataraman R; Zoghbi GJ; Perry GJ; DeMattos AM; Iskandrian AE
    J Am Coll Cardiol; 2009 Jun; 53(23):2129-40. PubMed ID: 19497438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?
    Schrier RW
    J Am Coll Cardiol; 2006 Jan; 47(1):1-8. PubMed ID: 16386657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for dosing antimicrobials.
    Hermsen ED; Maiefski M; Florescu MC; Qiu F; Rupp ME
    Pharmacotherapy; 2009 Jun; 29(6):649-55. PubMed ID: 19476418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Natural course of chronic kidney disease].
    Laville M; Rognant N
    Rev Prat; 2012 Jan; 62(1):30-3. PubMed ID: 22335063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of reduced renal function on prognosis in Japanese patients with coronary artery disease: a prospective cohort of Shinken Database 2007.
    Nakamura M; Yamashita T; Yajima J; Oikawa Y; Ogasawara K; Kirigaya H; Sagara K; Koike A; Sawada H; Aizawa T
    Hypertens Res; 2009 Oct; 32(10):920-6. PubMed ID: 19696780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hypertension, atherosclerosis and kidney].
    Zuccalà A; Fiorenza S; Rapanà R; Santoro A
    G Ital Nefrol; 2005; 22 Suppl 31():S9-14. PubMed ID: 15786409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic renal insufficiency and cardiovascular disease].
    Charriere S; Rognant N; Chiche F; Cremer A; Deray G; Priou M
    Ann Cardiol Angeiol (Paris); 2009 Feb; 58(1):40-52. PubMed ID: 18937921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal impairment: a risk factor for ischemic heart disease.
    Zoccali C
    Curr Opin Pharmacol; 2006 Apr; 6(2):221-5. PubMed ID: 16483843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection.
    Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Some important news in clinical nephrology in years 2003-2004].
    Tesar V
    Vnitr Lek; 2004 Oct; 50 Suppl 1():S81-7. PubMed ID: 15651147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal function assessment in the era of chronic kidney disease: renewed emphasis on renal function centered patient care.
    Lane BR; Poggio ED; Herts BR; Novick AC; Campbell SC
    J Urol; 2009 Aug; 182(2):435-43; discussion 443-4. PubMed ID: 19524967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inflammation, oxidative stress and kidney function in arterial hypertension].
    Cerasola G; Guarneri M; Cottone S
    G Ital Nefrol; 2009; 26 Suppl 46():8-13. PubMed ID: 19644813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension and coronary heart disease.
    Escobar E
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S61-3. PubMed ID: 11986897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin II receptor blockers in the treatment of the cardiovascular disease continuum.
    Chrysant SG
    Clin Ther; 2008; 30 Pt 2():2181-90. PubMed ID: 19281913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.